MAIA Biotechnology, Inc.
MAIA NYSE
SEC CIK 1878313
Follow MAIA Biotechnology
Weekly email: filings, results
Net income
−$7.2M
+19.4% vs same quarter last year
EPS, diluted
−$0.12
+55.6% vs same quarter last year
Operating cash flow
−$6.3M
−81% vs same quarter last year
Operating income
−$8M
+14.3% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | - | −$22.4M |
| FY24 | $0 | −$23.3M |
| FY23 | $0 | −$19.8M |
| FY22 | $0 | −$15.8M |
| FY21 | - | −$12.6M |
| FY20 | - | - |